Digital Therapeutics Market worth $17.7 billion by 2027 - Exclusive Report by MarketsandMarkets™
                     Digital Therapeutics (DTx) Market 
Global Forecast to 2027
Digital Therapeutics (DTx) Market  is 
expected to reach 
$17.7  Billion by 2027
Growing at a 
CAGR of  31.6% (2022 – 2027)
Request Sample
DIGITAL THERAPEUTICS (DTX) MARKET WORTH $17.7 BILLION BY 2027 
MARKET TWO OF THE KEY 
CAGR of 31.6 KEY MARKET OPPORTUNITY OVER DRIVERS OF THE 
2022-2027 PLAYERSNEXT 5 YEA1R7S.7 MARKET WILL BE:

CAGR 5 Bn Noom, Inc (US)4  Teladoc Health, Inc. (US)  Need to control 
3 4.5 Bn  Omada Health, Inc. (US) healthcare costs2
1
0
2022 2027
MARKET 
North America commanded SEGMENTATION 
the largest share of the BY EQUIPMENT 
digital therapeutics market CATEGORY:
 By application, 
treatment/care-related 
applications form the 
Growth in this market is largest segment of the 
primarily driven by the digital therapeutics 
government initiatives to market
support technological  The B2B segment is the 
developments, and largest and fastest-
advancements in the field of growing segment of the 
digital therapeutics to curb market during the 
growing healthcare costs. forecast period.
Medical Device Reprocessing Market worth $3.9 
billion by 2027
The report "Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance 
Abuse, Rehabilitation), Sales Channel B2C (Patient, Caregiver), B2B ( Providers, Payer, Employer, Pharma) - Global Forecasts to 2027" , is 
projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6%.
Browse 190 market data Tables and 33 Figures spread through 231 Pages and in-depth TOC on "Digital Therapeutics (DTx) Market by 
Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel B2C (Patient, 
Caregiver), B2B ( Providers, Payer, Employer, Pharma) - Global Forecasts to 2027“
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html
Medical Device Reprocessing Market worth $3.9 
billion by 2027
The digital therapeutics market is mainly driven by factors such as increasing investments in digital therapeutics, rising incidence of preventable 
chronic diseases, increasing government initiatives to support technological developments, and developments in the field of digital therapeutics to 
curb growing healthcare costs. However, hesitancy among patients to adopt digital therapeutics, and uneven payment models are challenging the 
growth of this market.
Treatment/care-related applications segment is expected to account for the largest share of the digital therapeutics market in 2022
Based on application digital therapeutics market is segmented into preventive and treatment/care-related applications. The treatment/care-related 
applications segment is expected to hold the largest share of this market in 2022. The growth of this segment is primarily attributed to the 
increasing healthcare costs, the rising prevalence of chronic diseases, and the ability of digital therapeutics to deliver cost-effective solutions.
Medical Device Reprocessing Market worth $3.9 
billion by 2027
B2B segment is estimated to account for the largest share of the digital therapeutics market
Based on sales channel, digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). The B2B 
segment is estimated to account for the largest share of the digital therapeutics market in 2022. Factors such as increasing partnership between 
many leading digital therapeutics provider companies and payers, providers, and employers to enhance their customer base are driving the B2B 
sales of digital therapeutics solutions.
North America is expected to hold the largest share of the digital therapeutics market in 2022
The digital therapeutics market has been segmented into four main regional segments: North America, Europe, the Asia Pacific, and Rest of the 
World. North America is expected to hold the largest share of this market, followed by Europe in 2022. The market in North America is also 
expected to grow at the highest CAGR. The large share can be attributed to the rising number of new start-ups in digital therapeutics market and 
slowly developing reimbursement structures for digital therapeutics solutions.
Medical Device Reprocessing Market worth $3.9 
billion by 2027
Prominent players in the digital therapeutics market include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc 
(US), Pear Therapeutics, Inc. (US), CogniFit Inc (US), Ginger (US), Propeller Health (US), 2Morrow, Inc. (US), Canary Health (US), Click 
Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Twill Inc. (US), Better Therapeutics, Inc (US), 
Mindstrong (US), Kaia Health (Germany), BehaVR Inc (US), Ayogo (Canada), Mindable Health GmbH (Germany), Virta Health Corp (US), Hinge 
Health, Inc. (US), Orexo AB (Sweden) and Freespira (US).
Don’t miss out on business opportunities in Digital Therapeutics (DTx
) Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% 
of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as 
clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues 
decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement 
Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, 
write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. 
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, 
innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 
10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing 
them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets 
and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]